Actavis blockbuster fails to halt US corporate surge
The US investment grade corporate feeding frenzy intensified this week as buyers snapped up more than $20bn of paper in addition to Actavis’s blockbusting $21bn deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts